| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | RAB9B DNAH3 ABCA2 TDRD9 KIF26A LRRK2 CCT2 GIMAP7 XRCC5 TRIP13 DDX27 RAB9A ABCB10 MACF1 GNA11 GNAQ DNAH9 RHOF DYNC1H1 DNAH11 | 1.41e-07 | 775 | 130 | 20 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | RAB9B DNAH3 ABCA2 TDRD9 KIF26A LRRK2 CCT2 GIMAP7 XRCC5 TRIP13 DDX27 RAB9A ABCB10 MACF1 GNA11 GNAQ DNAH9 RHOF DYNC1H1 DNAH11 | 4.99e-07 | 839 | 130 | 20 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | RAB9B DNAH3 ABCA2 TDRD9 KIF26A LRRK2 CCT2 GIMAP7 XRCC5 TRIP13 DDX27 RAB9A ABCB10 MACF1 GNA11 GNAQ DNAH9 RHOF DYNC1H1 DNAH11 | 5.08e-07 | 840 | 130 | 20 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | RAB9B DNAH3 ABCA2 TDRD9 KIF26A LRRK2 CCT2 GIMAP7 XRCC5 TRIP13 DDX27 RAB9A ABCB10 MACF1 GNA11 GNAQ DNAH9 RHOF DYNC1H1 DNAH11 | 5.08e-07 | 840 | 130 | 20 | GO:0016818 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 4.89e-06 | 18 | 130 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DNAH3 ABCA2 TDRD9 KIF26A CCT2 XRCC5 TRIP13 DDX27 ABCB10 MACF1 DNAH9 DYNC1H1 DNAH11 | 6.27e-06 | 441 | 130 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | microtubule motor activity | 6.32e-06 | 70 | 130 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | RAB9B PDE6C LRRK2 GIMAP7 SRPRB SH3BP4 RANBP17 RAB9A GUCY1A1 GNA11 GNAQ RHOF | 3.05e-05 | 439 | 130 | 12 | GO:0032561 |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | RAB9B PDE6C LRRK2 GIMAP7 SRPRB SH3BP4 RANBP17 RAB9A GUCY1A1 GNA11 GNAQ RHOF | 3.05e-05 | 439 | 130 | 12 | GO:0019001 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 3.11e-05 | 28 | 130 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DNAH3 ABCA2 TDRD9 KIF26A CCT2 XRCC5 TRIP13 DDX27 ABCB10 STARD9 MACF1 DNAH9 DYNC1H1 DNAH11 | 4.80e-05 | 614 | 130 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 9.59e-05 | 37 | 130 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.23e-04 | 118 | 130 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | GTP binding | RAB9B LRRK2 GIMAP7 SRPRB RANBP17 RAB9A GUCY1A1 GNA11 GNAQ RHOF | 2.76e-04 | 397 | 130 | 10 | GO:0005525 |
| GeneOntologyMolecularFunction | alkylglycerophosphoethanolamine phosphodiesterase activity | 4.15e-04 | 5 | 130 | 2 | GO:0047391 | |
| GeneOntologyMolecularFunction | phosphoric diester hydrolase activity | 4.32e-04 | 97 | 130 | 5 | GO:0008081 | |
| GeneOntologyMolecularFunction | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity | 1.15e-03 | 8 | 130 | 2 | GO:0004571 | |
| GeneOntologyMolecularFunction | double-stranded telomeric DNA binding | 1.47e-03 | 9 | 130 | 2 | GO:0003691 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | DNAH3 DPYSL3 WAS KIF26A KRT74 KRT83 TOGARAM1 TSC1 CCT2 SRPRB SPTBN4 KRT75 MACF1 EIF3A DNAH9 CEP170B DYNC1H1 DNAH11 | 1.17e-05 | 899 | 130 | 18 | GO:0099513 |
| GeneOntologyCellularComponent | supramolecular fiber | CACNA1D DNAH3 DPYSL3 WAS KIF26A KRT74 KRT83 TOGARAM1 TSC1 CCT2 SRPRB SPTBN4 KRT75 MACF1 EIF3A DNAH9 CEP170B DYNC1H1 DNAH11 | 1.26e-04 | 1179 | 130 | 19 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | CACNA1D DNAH3 DPYSL3 WAS KIF26A KRT74 KRT83 TOGARAM1 TSC1 CCT2 SRPRB SPTBN4 KRT75 MACF1 EIF3A DNAH9 CEP170B DYNC1H1 DNAH11 | 1.37e-04 | 1187 | 130 | 19 | GO:0099081 |
| GeneOntologyCellularComponent | dynein complex | 3.55e-04 | 54 | 130 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | microtubule | DNAH3 KIF26A TOGARAM1 CCT2 SRPRB MACF1 EIF3A DNAH9 CEP170B DYNC1H1 DNAH11 | 5.05e-04 | 533 | 130 | 11 | GO:0005874 |
| GeneOntologyCellularComponent | cell cortex | 5.30e-04 | 371 | 130 | 9 | GO:0005938 | |
| GeneOntologyCellularComponent | interphotoreceptor matrix | 5.66e-04 | 6 | 130 | 2 | GO:0033165 | |
| GeneOntologyCellularComponent | cell body | CACNA1D DPYSL3 SPTBN2 LRRK2 HIP1R CCT2 GRM7 PITPNM1 SPTBN4 HMCN2 ZPR1 KCNJ14 MAST1 GNAQ DYNC1H1 | 6.68e-04 | 929 | 130 | 15 | GO:0044297 |
| GeneOntologyCellularComponent | Cdc73/Paf1 complex | 7.90e-04 | 7 | 130 | 2 | GO:0016593 | |
| GeneOntologyCellularComponent | lipid droplet | 7.96e-04 | 116 | 130 | 5 | GO:0005811 | |
| GeneOntologyCellularComponent | spectrin | 1.34e-03 | 9 | 130 | 2 | GO:0008091 | |
| Domain | P-loop_NTPase | RAB9B DNAH3 ABCA2 TDRD9 KIF26A LRRK2 CMPK2 GIMAP7 TRIP13 SRPRB DDX27 RAB9A ABCB10 STARD9 GNA11 GNAQ DNAH9 RHOF DYNC1H1 DNAH11 | 1.86e-06 | 848 | 131 | 20 | IPR027417 |
| Domain | Dynein_heavy_chain_D4_dom | 2.19e-06 | 14 | 131 | 4 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.19e-06 | 14 | 131 | 4 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.19e-06 | 14 | 131 | 4 | IPR013602 | |
| Domain | DHC_N2 | 2.19e-06 | 14 | 131 | 4 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 2.19e-06 | 14 | 131 | 4 | IPR011704 | |
| Domain | MT | 2.19e-06 | 14 | 131 | 4 | PF12777 | |
| Domain | AAA_8 | 2.19e-06 | 14 | 131 | 4 | PF12780 | |
| Domain | AAA_5 | 2.19e-06 | 14 | 131 | 4 | PF07728 | |
| Domain | DHC_fam | 2.97e-06 | 15 | 131 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 2.97e-06 | 15 | 131 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.97e-06 | 15 | 131 | 4 | IPR004273 | |
| Domain | ARM-like | COPB1 TNPO2 LRRK2 TOGARAM1 COPG2 HUWE1 TEX10 RANBP17 FHOD1 PDS5A ARMC6 | 3.22e-06 | 270 | 131 | 11 | IPR011989 |
| Domain | - | COPB1 TNPO2 LRRK2 TOGARAM1 COPG2 TEX10 RANBP17 FHOD1 PDS5A ARMC6 | 3.79e-06 | 222 | 131 | 10 | 1.25.10.10 |
| Domain | - | RAB9B DNAH3 ABCA2 TDRD9 LRRK2 CMPK2 GIMAP7 TRIP13 SRPRB DDX27 RAB9A ABCB10 GNA11 GNAQ DNAH9 RHOF DYNC1H1 DNAH11 | 4.70e-06 | 746 | 131 | 18 | 3.40.50.300 |
| Domain | DHC_N1 | 1.84e-05 | 8 | 131 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.84e-05 | 8 | 131 | 3 | IPR013594 | |
| Domain | Glyco_hydro_47 | 1.84e-05 | 8 | 131 | 3 | IPR001382 | |
| Domain | ARM-type_fold | COPB1 TNPO2 LRRK2 TOGARAM1 COPG2 HUWE1 TEX10 RANBP17 FHOD1 PDS5A ARMC6 | 2.73e-05 | 339 | 131 | 11 | IPR016024 |
| Domain | AAA | 7.04e-05 | 144 | 131 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 7.04e-05 | 144 | 131 | 7 | IPR003593 | |
| Domain | HEAT_REPEAT | 1.32e-04 | 70 | 131 | 5 | PS50077 | |
| Domain | Spectrin_bsu | 2.90e-04 | 4 | 131 | 2 | IPR016343 | |
| Domain | Gprotein_alpha_Q | 2.90e-04 | 4 | 131 | 2 | IPR000654 | |
| Domain | Spectrin | 5.39e-04 | 23 | 131 | 3 | PF00435 | |
| Domain | ACTININ_2 | 5.39e-04 | 23 | 131 | 3 | PS00020 | |
| Domain | ACTININ_1 | 5.39e-04 | 23 | 131 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 5.39e-04 | 23 | 131 | 3 | IPR001589 | |
| Domain | Keratin_2_head | 6.13e-04 | 24 | 131 | 3 | IPR032444 | |
| Domain | Keratin_2_head | 6.13e-04 | 24 | 131 | 3 | PF16208 | |
| Domain | Keratin_II | 7.79e-04 | 26 | 131 | 3 | IPR003054 | |
| Domain | FHA | 9.72e-04 | 28 | 131 | 3 | SM00240 | |
| Domain | Glyco_hydro_47 | 1.00e-03 | 7 | 131 | 2 | PF01532 | |
| Domain | - | 1.00e-03 | 7 | 131 | 2 | 1.50.10.50 | |
| Domain | Spectrin_repeat | 1.08e-03 | 29 | 131 | 3 | IPR002017 | |
| Domain | FHA | 1.31e-03 | 31 | 131 | 3 | PF00498 | |
| Domain | SPEC | 1.44e-03 | 32 | 131 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.44e-03 | 32 | 131 | 3 | IPR018159 | |
| Domain | PH_dom-spectrin-type | 1.70e-03 | 9 | 131 | 2 | IPR001605 | |
| Domain | - | 2.03e-03 | 36 | 131 | 3 | 2.60.200.20 | |
| Domain | FHA_dom | 2.03e-03 | 36 | 131 | 3 | IPR000253 | |
| Domain | WWE | 3.08e-03 | 12 | 131 | 2 | PF02825 | |
| Domain | WWE-dom | 3.08e-03 | 12 | 131 | 2 | IPR004170 | |
| Domain | WWE | 3.08e-03 | 12 | 131 | 2 | PS50918 | |
| Domain | uDENN | 4.20e-03 | 14 | 131 | 2 | SM00800 | |
| Domain | Clathrin/coatomer_adapt-like_N | 4.83e-03 | 15 | 131 | 2 | IPR002553 | |
| Domain | uDENN | 4.83e-03 | 15 | 131 | 2 | PF03456 | |
| Domain | Adaptin_N | 4.83e-03 | 15 | 131 | 2 | PF01602 | |
| Domain | IBN_N | 4.83e-03 | 15 | 131 | 2 | PF03810 | |
| Domain | GproteinA_insert | 5.49e-03 | 16 | 131 | 2 | IPR011025 | |
| Domain | DENN | 5.49e-03 | 16 | 131 | 2 | SM00799 | |
| Domain | IBN_N | 5.49e-03 | 16 | 131 | 2 | SM00913 | |
| Domain | - | 5.49e-03 | 16 | 131 | 2 | 1.10.400.10 | |
| Domain | DENN | 5.49e-03 | 16 | 131 | 2 | PF02141 | |
| Domain | dDENN | 5.49e-03 | 16 | 131 | 2 | PF03455 | |
| Domain | G-alpha | 5.49e-03 | 16 | 131 | 2 | PF00503 | |
| Domain | UDENN | 5.49e-03 | 16 | 131 | 2 | PS50946 | |
| Domain | DDENN | 5.49e-03 | 16 | 131 | 2 | PS50947 | |
| Domain | dDENN | 5.49e-03 | 16 | 131 | 2 | SM00801 | |
| Domain | dDENN_dom | 5.49e-03 | 16 | 131 | 2 | IPR005112 | |
| Domain | uDENN_dom | 5.49e-03 | 16 | 131 | 2 | IPR005113 | |
| Domain | DENN | 5.49e-03 | 16 | 131 | 2 | PS50211 | |
| Domain | DENN_dom | 5.49e-03 | 16 | 131 | 2 | IPR001194 | |
| Domain | Ald_DH_CS_GLU | 5.49e-03 | 16 | 131 | 2 | IPR029510 | |
| Domain | G_alpha | 5.49e-03 | 16 | 131 | 2 | SM00275 | |
| Domain | SMAD_FHA_domain | 5.80e-03 | 52 | 131 | 3 | IPR008984 | |
| Domain | Importin-beta_N | 6.20e-03 | 17 | 131 | 2 | IPR001494 | |
| Domain | Gprotein_alpha_su | 6.20e-03 | 17 | 131 | 2 | IPR001019 | |
| Domain | Ald_DH_CS_CYS | 6.20e-03 | 17 | 131 | 2 | IPR016160 | |
| Domain | ALDEHYDE_DEHYDR_CYS | 6.94e-03 | 18 | 131 | 2 | PS00070 | |
| Domain | ALDEHYDE_DEHYDR_GLU | 6.94e-03 | 18 | 131 | 2 | PS00687 | |
| Pathway | REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS | 3.10e-05 | 120 | 105 | 7 | MM14585 | |
| Pathway | REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS | 4.70e-05 | 128 | 105 | 7 | M706 | |
| Pathway | REACTOME_PHOSPHOLIPID_METABOLISM | 1.07e-04 | 196 | 105 | 8 | MM14591 | |
| Pubmed | IRS4 NUP107 COPB1 PDHA1 SPTBN2 COPG2 CCT2 HUWE1 KRR1 XRCC5 TEX10 DDX27 XAB2 ZCCHC3 SBF1 MKI67 MACF1 PDS5A DYNC1H1 | 6.98e-12 | 653 | 132 | 19 | 22586326 | |
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | LPCAT1 COPB1 PDHA1 COPG2 HUWE1 TRIP13 SRPRB SH3BP4 MACF1 CDC73 DYNC1H1 ARMC6 | 1.17e-10 | 235 | 132 | 12 | 28378594 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NUP107 COPB1 PDHA1 HIP1R TSC1 CCT2 HUWE1 KRR1 XRCC5 TEX10 TRIP13 SRPRB DDX27 SBF1 CTR9 FHOD1 SHCBP1 MKI67 MACF1 PDS5A EIF3A DYNC1H1 ALDH7A1 | 1.60e-09 | 1353 | 132 | 23 | 29467282 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | PRPSAP1 LPCAT1 ACADVL APEX1 TSC1 CCT2 HUWE1 KRR1 XRCC5 PPWD1 TRIP13 SRPRB XAB2 RPS26P11 KRT75 JMJD6 CTR9 FHOD1 MACF1 PDS5A EIF3A CDC73 DYNC1H1 | 3.73e-09 | 1415 | 132 | 23 | 28515276 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | COPB1 ACADVL PDHA1 COPG2 CCT2 HUWE1 KRR1 XRCC5 TRIP13 SRPRB DDX27 XAB2 ZCCHC3 VPS52 ABCB10 JMJD6 CTR9 MKI67 EIF3A PSMD14 DYNC1H1 ARMC6 | 5.28e-09 | 1318 | 132 | 22 | 30463901 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | IRS4 NUP107 COPB1 ACADVL DSG2 SPTBN2 CCT2 HUWE1 XRCC5 TEX10 TRIP13 SRPRB DDX27 XAB2 RAB9A MKI67 MACF1 EIF3A DYNC1H1 | 1.24e-08 | 1024 | 132 | 19 | 24711643 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | IRS4 NUP107 COPB1 DSG2 PDHA1 CCT2 HUWE1 KRR1 XRCC5 TRIP13 SRPRB DDX27 RAB9A RPS26P11 CTR9 STARD9 MKI67 PDS5A EIF3A CDC73 PSMD14 DYNC1H1 | 2.13e-08 | 1425 | 132 | 22 | 30948266 |
| Pubmed | IRS4 NUP107 COPB1 DSG2 COPG2 CCT2 HUWE1 XRCC5 TRIP13 CTR9 PDS5A EIF3A CDC73 PSMD14 DYNC1H1 | 2.27e-08 | 638 | 132 | 15 | 33239621 | |
| Pubmed | DENND2A DPYSL3 COPB1 PDHA1 SPTBN2 TSC1 CCT2 PITPNM1 GPD1L SPTBN4 SLC44A1 SBF1 HECW2 VCAN MAST1 MACF1 EIF3A GNAQ CEP170B DYNC1H1 ALDH7A1 DNAH11 | 2.30e-08 | 1431 | 132 | 22 | 37142655 | |
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | LPCAT1 IRS4 COPB1 PDHA1 COPG2 CCT2 XRCC5 TRIP13 SRPRB RAB9A RPS26P11 ABCB10 PSMD14 DYNC1H1 | 3.60e-08 | 565 | 132 | 14 | 33567341 |
| Pubmed | 3.83e-08 | 130 | 132 | 8 | 12421765 | ||
| Pubmed | ABCA2 COPB1 TNPO2 KRT83 SPTBN2 CCT2 ZNF227 HUWE1 DDX27 XAB2 SPTBN4 CTR9 MAST1 MACF1 TMEM131 GFPT2 ALDH5A1 DYNC1H1 PLXNB3 SOS2 | 8.85e-08 | 1285 | 132 | 20 | 35914814 | |
| Pubmed | PRPSAP1 COPB1 HIP1R APEX1 XRCC5 PARP14 SRPRB DDX27 ZCCHC3 SERPINE1 MACF1 EIF3A PSMD14 DYNC1H1 ALDH7A1 | 9.30e-08 | 711 | 132 | 15 | 33022573 | |
| Pubmed | IRS4 NUP107 COPB1 PDHA1 COPG2 HUWE1 XRCC5 TRIP13 EIF3A CDC73 PSMD14 ALDH5A1 DYNC1H1 | 1.39e-07 | 534 | 132 | 13 | 35032548 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | DNAH3 TNPO2 SPTBN2 HUWE1 GIMAP7 XRCC5 PARP14 LGALSL PTPRN2 HECW2 CCDC87 PDS5A EIF3A DYNC1H1 PLXNB3 | 1.45e-07 | 736 | 132 | 15 | 29676528 |
| Pubmed | IRS4 NUP107 COPB1 ACADVL TNPO2 COPG2 TEX10 XAB2 VPS52 ABCB10 CTR9 PDS5A DYNC1H1 | 2.39e-07 | 560 | 132 | 13 | 35241646 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | PRPSAP1 COPB1 ACADVL COPG2 CCT2 HUWE1 SRPRB KRT75 JMJD6 CTR9 EIF3A GFPT2 PSMD14 DYNC1H1 | 2.63e-07 | 665 | 132 | 14 | 30457570 |
| Pubmed | ZBTB33 NUP107 COPB1 DSG2 LRRK2 COPG2 CCT2 HUWE1 SRPRB SH3BP4 VPS52 MKI67 PDS5A PCDH7 DYNC1H1 | 2.89e-07 | 777 | 132 | 15 | 35844135 | |
| Pubmed | DPYSL3 IRS4 NUP107 SPTBN2 COPG2 TSC1 CCT2 HUWE1 TEX10 DDX27 PTPRE SBF1 PTPRN2 CTR9 MKI67 PSMD14 PCDH7 | 5.16e-07 | 1049 | 132 | 17 | 27880917 | |
| Pubmed | PRPSAP1 NUP107 COPB1 DSG2 HIP1R HUWE1 TRIP13 SRPRB VPS52 ABCB10 PDS5A TMEM131 CDC73 | 5.83e-07 | 606 | 132 | 13 | 36538041 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | ZBTB33 NUP107 CCT2 HUWE1 XRCC5 TRIP13 XAB2 CTR9 PDS5A DYNC1H1 | 6.12e-07 | 332 | 132 | 10 | 32786267 |
| Pubmed | 1.21e-06 | 204 | 132 | 8 | 25659154 | ||
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | 1.28e-06 | 90 | 132 | 6 | 35654790 | |
| Pubmed | LPCAT1 DPYSL3 NUP107 DSG2 COPG2 CCT2 HUWE1 XRCC5 TIMMDC1 SRPRB GPD1L ABCB10 ZPR1 FHOD1 DYNC1H1 | 1.33e-06 | 878 | 132 | 15 | 37223481 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | SPTBN2 PITPNM1 MACF1 AKAP11 GNA11 GNAQ PCDH7 CEP170B DYNC1H1 | 1.38e-06 | 281 | 132 | 9 | 28706196 |
| Pubmed | IRS4 PDHA1 CCT2 HUWE1 XRCC5 TRIP13 SRPRB CTR9 MKI67 CDC73 DYNC1H1 | 1.69e-06 | 463 | 132 | 11 | 34901782 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | DPYSL3 IRS4 COPB1 TNPO2 SPTBN2 APEX1 COPG2 CCT2 HUWE1 XRCC5 TRIP13 MACF1 PDS5A EIF3A PSMD14 DYNC1H1 ALDH7A1 | 1.79e-06 | 1149 | 132 | 17 | 35446349 |
| Pubmed | IRS4 ZBTB33 NUP107 COPB1 KRT74 TNPO2 CCT2 KRR1 XRCC5 TEX10 DDX27 ZCCHC3 MKI67 PDS5A EIF3A GFPT2 PSMD14 PCDH7 DYNC1H1 | 2.03e-06 | 1429 | 132 | 19 | 35140242 | |
| Pubmed | PRPSAP1 IRS4 COPB1 TNPO2 SPTBN2 COPG2 CCT2 HUWE1 KRR1 XRCC5 TRIP13 SRPRB DDX27 SERPINE1 MKI67 PDS5A EIF3A PSMD14 DYNC1H1 | 2.27e-06 | 1440 | 132 | 19 | 30833792 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ABCA2 IRS4 COPB1 ACADVL APEX1 COPG2 CCT2 HUWE1 XRCC5 RPS26P11 MACF1 EIF3A PSMD14 DYNC1H1 | 2.57e-06 | 807 | 132 | 14 | 30575818 |
| Pubmed | WAS KIF26A SPTBN2 DDX27 SH3BP4 USF3 FHOD1 MACF1 EIF3A ARHGAP33 SOS2 | 2.69e-06 | 486 | 132 | 11 | 20936779 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | DPYSL3 IRS4 ZBTB33 NUP107 COPB1 DSG2 COPG2 TSC1 CCT2 XRCC5 XAB2 FHOD1 MKI67 MACF1 EIF3A | 2.83e-06 | 934 | 132 | 15 | 33916271 |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 2.98e-06 | 104 | 132 | 6 | 31240132 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | LPCAT1 NUP107 COPB1 DSG2 COPG2 HUWE1 TEX10 TIMMDC1 TRIP13 SRPRB RNF43 VPS52 ABCB10 PDS5A DYNC1H1 | 3.14e-06 | 942 | 132 | 15 | 31073040 |
| Pubmed | 3.25e-06 | 233 | 132 | 8 | 37704626 | ||
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 4.32e-06 | 171 | 132 | 7 | 20201926 | |
| Pubmed | IRS4 COPB1 COPG2 CCT2 HUWE1 KRR1 XRCC5 DDX27 ZCCHC3 CTR9 QPRT PDS5A EIF3A CDC73 PSMD14 | 4.53e-06 | 971 | 132 | 15 | 33306668 | |
| Pubmed | 4.65e-06 | 64 | 132 | 5 | 22865885 | ||
| Pubmed | 5.36e-06 | 332 | 132 | 9 | 25693804 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | LPCAT1 IRS4 COPB1 ACADVL COPG2 CCT2 HUWE1 XRCC5 ABCB10 EIF3A PSMD14 DYNC1H1 | 7.12e-06 | 647 | 132 | 12 | 26618866 |
| Pubmed | 7.25e-06 | 70 | 132 | 5 | 21726808 | ||
| Pubmed | 7.45e-06 | 33 | 132 | 4 | 26296893 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 7.50e-06 | 440 | 132 | 10 | 34244565 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 8.00e-06 | 349 | 132 | 9 | 25665578 | |
| Pubmed | COPB1 KRT74 COPG2 CCT2 KRR1 XRCC5 ZCCHC3 USF3 RPS26P11 KRT75 CTR9 MACF1 EIF3A CDC73 PSMD14 DYNC1H1 | 8.23e-06 | 1153 | 132 | 16 | 29845934 | |
| Pubmed | NUP107 DSG2 PDHA1 XRCC5 PPWD1 CTR9 MKI67 MACF1 GNA11 EIF3A CDC73 PLD2 | 8.69e-06 | 660 | 132 | 12 | 32780723 | |
| Pubmed | PRPSAP1 IRS4 SPTBN2 CCT2 HUWE1 KRR1 XRCC5 XAB2 ZCCHC3 EIF3A CDC73 | 8.80e-06 | 551 | 132 | 11 | 34728620 | |
| Pubmed | 8.94e-06 | 449 | 132 | 10 | 31732153 | ||
| Pubmed | Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation. | 9.29e-06 | 269 | 132 | 8 | 30442662 | |
| Pubmed | IRS4 NUP107 DSG2 PDHA1 APEX1 CCT2 HUWE1 XRCC5 RAB9A EIF3A PSMD14 DYNC1H1 ALDH7A1 | 9.93e-06 | 786 | 132 | 13 | 29128334 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PRPSAP1 DPYSL3 COPB1 PDHA1 APEX1 CCT2 HUWE1 XRCC5 TRIP13 JMJD6 CTR9 ZPR1 MACF1 EIF3A CDC73 PSMD14 DYNC1H1 ALDH7A1 | 1.03e-05 | 1455 | 132 | 18 | 22863883 |
| Pubmed | Family-wide characterization of the DENN domain Rab GDP-GTP exchange factors. | 1.19e-05 | 37 | 132 | 4 | 20937701 | |
| Pubmed | DNAH3 DPYSL3 ACADVL COPG2 TSC1 CCT2 XRCC5 SRPRB MKI67 EIF3A PSMD14 DYNC1H1 SOS2 | 1.24e-05 | 803 | 132 | 13 | 36517590 | |
| Pubmed | NUP107 ACADVL DSG2 PDHA1 SPTBN2 XRCC5 HSPA12B TIMMDC1 SRPRB DDX27 SH3BP4 ABCB10 SBF1 CTR9 MACF1 AKAP11 TMEM131 PCDH7 | 1.38e-05 | 1487 | 132 | 18 | 33957083 | |
| Pubmed | The Role of Mutation Rates of GNAQ or GNA11 in Cases of Uveal Melanoma in Japan. | 1.43e-05 | 2 | 132 | 2 | 28248732 | |
| Pubmed | Activation of Gq/11 in the mouse corpus luteum is required for parturition. | 1.43e-05 | 2 | 132 | 2 | 25495873 | |
| Pubmed | Molecular genetic testing of uveal melanoma from routinely processed and stained cytology specimens. | 1.43e-05 | 2 | 132 | 2 | 21945171 | |
| Pubmed | Ku antigen displays the AP lyase activity on a certain type of duplex DNA. | 1.43e-05 | 2 | 132 | 2 | 27129632 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 9175863 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 28083870 | ||
| Pubmed | Gq/11-Dependent Changes in the Murine Ovarian Transcriptome at the End of Gestation. | 1.43e-05 | 2 | 132 | 2 | 26843449 | |
| Pubmed | Direct targeting of Gαq and Gα11 oncoproteins in cancer cells. | 1.43e-05 | 2 | 132 | 2 | 30890659 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 9607776 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 31726051 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 11438569 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 37802294 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 26628681 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 17552882 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 31173078 | ||
| Pubmed | Frequent and Yet Unreported GNAQ and GNA11 Mutations are Found in Uveal Melanomas. | 1.43e-05 | 2 | 132 | 2 | 29209985 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 16140752 | ||
| Pubmed | Distinct roles of Galpha(q) and Galpha11 for Purkinje cell signaling and motor behavior. | 1.43e-05 | 2 | 132 | 2 | 15175381 | |
| Pubmed | Oncogenic GNAQ and GNA11 mutations in uveal melanoma in Chinese. | 1.43e-05 | 2 | 132 | 2 | 25280020 | |
| Pubmed | GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosis. | 1.43e-05 | 2 | 132 | 2 | 27498141 | |
| Pubmed | Uveal Melanoma: GNAQ and GNA11 Mutations in a Greek Population. | 1.43e-05 | 2 | 132 | 2 | 28982892 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 21083380 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 25304237 | ||
| Pubmed | Epidermal loss of Gαq confers a migratory and differentiation defect in keratinocytes. | 1.43e-05 | 2 | 132 | 2 | 28301547 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 16847339 | ||
| Pubmed | Uveal melanoma driver mutations in GNAQ/11 yield numerous changes in melanocyte biology. | 1.43e-05 | 2 | 132 | 2 | 29570931 | |
| Pubmed | Muscarinic inhibition of calcium current and M current in Galpha q-deficient mice. | 1.43e-05 | 2 | 132 | 2 | 10818132 | |
| Pubmed | Endothelial Gαq/11 is required for VEGF-induced vascular permeability and angiogenesis. | 1.43e-05 | 2 | 132 | 2 | 26272756 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 31461351 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 23634288 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 26368812 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 17482476 | ||
| Pubmed | Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations. | 1.43e-05 | 2 | 132 | 2 | 24141786 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 22362780 | ||
| Pubmed | Stretch regulates alveologenesis and homeostasis via mesenchymal Gαq/11-mediated TGFβ2 activation. | 1.43e-05 | 2 | 132 | 2 | 37102682 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 7492305 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 24308950 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 22562663 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 11826096 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 21366456 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 35580369 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 21788586 | ||
| Pubmed | Papillary Hemangioma Harbors Somatic GNA11 and GNAQ Mutations. | 1.43e-05 | 2 | 132 | 2 | 37750536 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 26778290 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 33567543 | ||
| Pubmed | Skeletal Muscle-Specific Activation of Gq Signaling Maintains Glucose Homeostasis. | 1.43e-05 | 2 | 132 | 2 | 30936140 | |
| Interaction | TES interactions | LPCAT1 COPB1 PDHA1 APEX1 COPG2 HUWE1 TRIP13 SRPRB RNF43 SH3BP4 ZPR1 MACF1 CDC73 DYNC1H1 ARMC6 | 3.99e-09 | 332 | 130 | 15 | int:TES |
| Interaction | YWHAZ interactions | IRS4 ZBTB33 PDE6C NUP107 COPB1 DSG2 SPTBN2 LRRK2 HIP1R TSC1 HUWE1 KRR1 SH3BP4 SBF1 STARD9 FHOD1 SHCBP1 MAST1 MACF1 AKAP11 EIF3A CDC73 PSMD14 PCDH7 CEP170B DYNC1H1 | 2.69e-07 | 1319 | 130 | 26 | int:YWHAZ |
| Interaction | SIRT7 interactions | IRS4 NUP107 COPB1 PDHA1 SPTBN2 COPG2 CCT2 HUWE1 KRR1 XRCC5 TEX10 DDX27 XAB2 ZCCHC3 SBF1 MKI67 MACF1 PDS5A DYNC1H1 | 3.07e-07 | 744 | 130 | 19 | int:SIRT7 |
| Interaction | CDC42 interactions | PRPSAP1 LPCAT1 IRS4 PDE6C WAS ACADVL DSG2 SPTBN2 LRRK2 APEX1 HUWE1 TEX10 SRPRB SH3BP4 VPS52 RAB9A SBF1 FHOD1 MKI67 GNA11 TMEM131 PCDH7 RHOF ARHGAP33 ARMC6 | 1.04e-06 | 1323 | 130 | 25 | int:CDC42 |
| Interaction | CCDC8 interactions | IRS4 COPB1 ACADVL DSG2 SPTBN2 CCT2 HUWE1 XRCC5 TRIP13 SRPRB RAB9A PTPRN2 MKI67 MACF1 EIF3A RHOF DYNC1H1 | 1.12e-06 | 656 | 130 | 17 | int:CCDC8 |
| Interaction | BSG interactions | CLUAP1 DSG2 PDHA1 TNPO2 APEX1 HUWE1 HSPA12B TRIP13 GPD1L SPTBN4 VPS52 RAB9A PDS5A PLD2 RHOF ALDH7A1 | 3.14e-06 | 631 | 130 | 16 | int:BSG |
| Interaction | STIP1 interactions | IRS4 NUP107 COPB1 DSG2 LRRK2 COPG2 CCT2 HUWE1 XRCC5 TRIP13 RNF43 SBF1 CTR9 PDS5A EIF3A CDC73 PSMD14 PCDH7 RHOF DYNC1H1 | 6.91e-06 | 1006 | 130 | 20 | int:STIP1 |
| Interaction | YWHAB interactions | IRS4 PDE6C NUP107 DSG2 LRRK2 TSC1 KRR1 XRCC5 PPWD1 RNF43 SH3BP4 CTR9 STARD9 SHCBP1 MAST1 MACF1 AKAP11 CDC73 CEP170B DYNC1H1 | 7.76e-06 | 1014 | 130 | 20 | int:YWHAB |
| Interaction | AGAP2 interactions | 9.05e-06 | 210 | 130 | 9 | int:AGAP2 | |
| Interaction | KIF23 interactions | LPCAT1 COPB1 ACADVL DSG2 TNPO2 APEX1 COPG2 HUWE1 KRR1 XRCC5 TRIP13 SRPRB DDX27 RAB9A RPS26P11 SHCBP1 MKI67 MACF1 GNA11 DYNC1H1 | 9.91e-06 | 1031 | 130 | 20 | int:KIF23 |
| Interaction | XPOT interactions | 1.31e-05 | 220 | 130 | 9 | int:XPOT | |
| Interaction | RHOJ interactions | LPCAT1 IRS4 WAS DSG2 SPTBN2 SRPRB DDX27 SH3BP4 RAB9A SBF1 FHOD1 MACF1 GNA11 PCDH7 ARHGAP33 | 1.46e-05 | 633 | 130 | 15 | int:RHOJ |
| Interaction | RAC1 interactions | PRPSAP1 LPCAT1 IRS4 WAS DSG2 SPTBN2 LRRK2 TSC1 HUWE1 SRPRB SH3BP4 VPS52 RAB9A ABCB10 SBF1 FHOD1 MACF1 GNA11 PCDH7 ARHGAP33 | 1.55e-05 | 1063 | 130 | 20 | int:RAC1 |
| Interaction | CIT interactions | AMPD3 NUP107 COPB1 DSG2 PDHA1 TNPO2 SPTBN2 LRRK2 CCT2 XRCC5 TEX10 PPWD1 TRIP13 XAB2 SPTBN4 RPS26P11 CTR9 HECW2 MKI67 MACF1 PDS5A EIF3A CDC73 DYNC1H1 | 1.68e-05 | 1450 | 130 | 24 | int:CIT |
| Interaction | ABCE1 interactions | DSG2 PDHA1 APEX1 XRCC5 DDX27 STARD9 MACF1 GNA11 EIF3A GNAQ PSMD14 RHOF | 2.33e-05 | 431 | 130 | 12 | int:ABCE1 |
| Interaction | KCTD13 interactions | DENND2A DPYSL3 COPB1 PDHA1 SPTBN2 TSC1 CCT2 PITPNM1 GPD1L SPTBN4 SLC44A1 SBF1 HECW2 VCAN MAST1 MACF1 EIF3A GNAQ GFPT2 CEP170B DYNC1H1 ALDH7A1 DNAH11 | 2.72e-05 | 1394 | 130 | 23 | int:KCTD13 |
| Interaction | SINHCAF interactions | 2.76e-05 | 135 | 130 | 7 | int:SINHCAF | |
| Interaction | SUMO2 interactions | ZBTB33 NUP107 LRRK2 CCT2 HUWE1 XRCC5 TEX10 TRIP13 RNF43 XAB2 CTR9 MKI67 PDS5A DYNC1H1 | 2.87e-05 | 591 | 130 | 14 | int:SUMO2 |
| Interaction | RHOF interactions | LPCAT1 IRS4 DSG2 SPTBN2 HIP1R TEX10 SRPRB SH3BP4 VPS52 RAB9A SBF1 MACF1 PCDH7 RHOF ARMC6 | 2.96e-05 | 673 | 130 | 15 | int:RHOF |
| Interaction | SPRTN interactions | LPCAT1 IRS4 COPB1 PDHA1 COPG2 CCT2 HUWE1 TRIP13 SRPRB RAB9A RPS26P11 ABCB10 PSMD14 DYNC1H1 | 3.15e-05 | 596 | 130 | 14 | int:SPRTN |
| Interaction | CDC5L interactions | NUP107 COPB1 HIP1R COPG2 CCT2 HUWE1 KRR1 TEX10 PPWD1 TRIP13 XAB2 VPS52 FHOD1 MAST1 MACF1 CDC73 DYNC1H1 | 3.61e-05 | 855 | 130 | 17 | int:CDC5L |
| Interaction | SERBP1 interactions | LPCAT1 DPYSL3 NUP107 DSG2 PDHA1 TNPO2 COPG2 CCT2 HUWE1 KRR1 XRCC5 TEX10 TIMMDC1 SRPRB ZCCHC3 GPD1L HARS2 ABCB10 ZPR1 FHOD1 EIF3A PSMD14 DYNC1H1 | 4.14e-05 | 1432 | 130 | 23 | int:SERBP1 |
| Interaction | DNAJA1 interactions | CLUAP1 PDHA1 TNPO2 LRRK2 TSC1 CCT2 HUWE1 RNF43 JMJD6 CDC73 PLD2 PSMD14 PCDH7 | 4.17e-05 | 533 | 130 | 13 | int:DNAJA1 |
| Interaction | YWHAG interactions | DPYSL3 IRS4 ZBTB33 COPB1 DSG2 LRRK2 TSC1 CCT2 HUWE1 KRR1 DDX27 SH3BP4 SBF1 STARD9 SHCBP1 MACF1 AKAP11 PCDH7 CEP170B DYNC1H1 ALDH7A1 | 4.82e-05 | 1248 | 130 | 21 | int:YWHAG |
| Interaction | YWHAE interactions | PRPSAP1 IRS4 ZBTB33 LRRK2 TSC1 HUWE1 RNF43 SH3BP4 SBF1 ZPR1 SHCBP1 MAST1 MACF1 AKAP11 EIF3A CDC73 PCDH7 CEP170B DYNC1H1 ALDH7A1 ARHGAP33 | 5.29e-05 | 1256 | 130 | 21 | int:YWHAE |
| Interaction | PRC1 interactions | NUP107 COPB1 DSG2 PDHA1 SPTBN2 TSC1 CCT2 KRR1 XRCC5 TRIP13 DDX27 SPTBN4 USF3 RPS26P11 MKI67 PDS5A DYNC1H1 ARHGAP33 | 5.36e-05 | 973 | 130 | 18 | int:PRC1 |
| Interaction | NUDCD1 interactions | 5.38e-05 | 63 | 130 | 5 | int:NUDCD1 | |
| Interaction | CLEC16A interactions | PRPSAP1 NUP107 COPB1 DSG2 HIP1R APEX1 HUWE1 TRIP13 SRPRB VPS52 ABCB10 PDS5A TMEM131 CDC73 | 5.63e-05 | 629 | 130 | 14 | int:CLEC16A |
| Interaction | WDR91 interactions | 6.60e-05 | 34 | 130 | 4 | int:WDR91 | |
| Interaction | WDR5 interactions | PRPSAP1 CLUAP1 NUP107 COPB1 HIP1R APEX1 CCT2 XRCC5 PARP14 SRPRB DDX27 ZCCHC3 SBF1 SERPINE1 MACF1 EIF3A PSMD14 DYNC1H1 ALDH7A1 | 8.26e-05 | 1101 | 130 | 19 | int:WDR5 |
| Interaction | NR2C2 interactions | COPB1 ACADVL PDHA1 COPG2 CCT2 HUWE1 KRR1 XRCC5 TRIP13 SRPRB DDX27 XAB2 ZCCHC3 VPS52 ABCB10 JMJD6 CTR9 MKI67 EIF3A PSMD14 DYNC1H1 ARMC6 | 8.88e-05 | 1403 | 130 | 22 | int:NR2C2 |
| Interaction | YWHAQ interactions | IRS4 PDE6C NUP107 DSG2 LRRK2 TSC1 KRR1 RNF43 SH3BP4 SBF1 STARD9 SHCBP1 MACF1 AKAP11 CDC73 PCDH7 CEP170B DYNC1H1 ALDH7A1 | 1.01e-04 | 1118 | 130 | 19 | int:YWHAQ |
| Interaction | SRP9 interactions | CLUAP1 LRRK2 HUWE1 SRPRB JMJD6 CTR9 VCAN MAST1 EIF3A CDC73 RHOF | 1.03e-04 | 427 | 130 | 11 | int:SRP9 |
| Interaction | RHOC interactions | PRPSAP1 LPCAT1 DSG2 SPTBN2 APEX1 SRPRB SH3BP4 RAB9A SBF1 MACF1 GNA11 TMEM131 PCDH7 | 1.05e-04 | 584 | 130 | 13 | int:RHOC |
| Interaction | PCK1 interactions | 1.23e-04 | 119 | 130 | 6 | int:PCK1 | |
| Interaction | RHOQ interactions | IRS4 WAS COPB1 DSG2 SPTBN2 SH3BP4 RAB9A SBF1 GNA11 PCDH7 RHOF | 1.40e-04 | 442 | 130 | 11 | int:RHOQ |
| Interaction | WDR48 interactions | 1.53e-04 | 177 | 130 | 7 | int:WDR48 | |
| Interaction | CANX interactions | DNAH3 ABCA2 NUP107 COPB1 ACADVL DSG2 PDHA1 LRRK2 COPG2 HUWE1 SRPRB RNF43 EDEM3 SLC44A1 PTPRE JMJD6 EDEM2 CDC73 DNAH9 RHOF | 1.66e-04 | 1261 | 130 | 20 | int:CANX |
| Interaction | SPRYD7 interactions | 1.84e-04 | 44 | 130 | 4 | int:SPRYD7 | |
| Interaction | C9orf78 interactions | IRS4 NUP107 COPB1 ACADVL TNPO2 COPG2 TEX10 XAB2 VPS52 ABCB10 CTR9 PDS5A DYNC1H1 | 1.89e-04 | 620 | 130 | 13 | int:C9orf78 |
| Interaction | BIN1 interactions | 1.91e-04 | 129 | 130 | 6 | int:BIN1 | |
| Interaction | SIRT6 interactions | IRS4 NUP107 APEX1 HUWE1 XRCC5 TEX10 DDX27 SBF1 CTR9 MKI67 PDS5A GFPT2 PCDH7 | 2.14e-04 | 628 | 130 | 13 | int:SIRT6 |
| Interaction | NT5E interactions | 2.24e-04 | 85 | 130 | 5 | int:NT5E | |
| Interaction | CCT8 interactions | PDHA1 LRRK2 TSC1 CCT2 HUWE1 MACF1 EIF3A CDC73 GFPT2 PSMD14 PCDH7 ARMC6 | 2.35e-04 | 550 | 130 | 12 | int:CCT8 |
| Interaction | BOP1 interactions | 2.44e-04 | 191 | 130 | 7 | int:BOP1 | |
| Interaction | USP53 interactions | 2.75e-04 | 138 | 130 | 6 | int:USP53 | |
| Interaction | RNF126 interactions | 2.75e-04 | 138 | 130 | 6 | int:RNF126 | |
| Interaction | RNF123 interactions | DNAH3 TNPO2 SPTBN2 HUWE1 GIMAP7 XRCC5 PARP14 LGALSL PTPRN2 HECW2 CCDC87 PDS5A EIF3A DYNC1H1 PLXNB3 | 2.79e-04 | 824 | 130 | 15 | int:RNF123 |
| Interaction | TUBB interactions | DPYSL3 PDHA1 TNPO2 LRRK2 CCT2 HUWE1 RNF43 DHDH GFPT2 PLD2 PSMD14 PCDH7 DYNC1H1 ARMC6 | 2.86e-04 | 735 | 130 | 14 | int:TUBB |
| Interaction | TRMT1 interactions | 2.97e-04 | 140 | 130 | 6 | int:TRMT1 | |
| Interaction | PSMB3 interactions | 3.03e-04 | 198 | 130 | 7 | int:PSMB3 | |
| Interaction | LINC01554 interactions | 3.21e-04 | 142 | 130 | 6 | int:LINC01554 | |
| Interaction | TBC1D10B interactions | 3.25e-04 | 92 | 130 | 5 | int:TBC1D10B | |
| Interaction | USP14 interactions | IRS4 DSG2 SPTBN2 CCT2 XRCC5 TRIP13 SRPRB MACF1 GNA11 PSMD14 DYNC1H1 | 3.33e-04 | 489 | 130 | 11 | int:USP14 |
| Interaction | BIRC3 interactions | IRS4 NUP107 COPB1 DSG2 PDHA1 CCT2 HUWE1 KRR1 XRCC5 TRIP13 SRPRB RAB9A CTR9 STARD9 MKI67 PDS5A EIF3A CDC73 PSMD14 DYNC1H1 | 3.47e-04 | 1334 | 130 | 20 | int:BIRC3 |
| Interaction | ATP1A1 interactions | CACNA1D NUP107 PDHA1 CCT2 HUWE1 XRCC5 DDX27 RAB9A EIF3A RHOF DYNC1H1 ALDH7A1 | 3.52e-04 | 575 | 130 | 12 | int:ATP1A1 |
| GeneFamily | Dyneins, axonemal | 6.73e-05 | 17 | 86 | 3 | 536 | |
| GeneFamily | Keratins, type II | 2.80e-04 | 27 | 86 | 3 | 609 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Paf1/RNA polymerase II complex | 3.31e-04 | 6 | 86 | 2 | 1029 | |
| GeneFamily | EF-hand domain containing|Spectrins | 4.62e-04 | 7 | 86 | 2 | 1113 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | LPCAT1 DPYSL3 ABCA2 TRO KRT83 SPTBN2 CCT2 CACFD1 HUWE1 TIMMDC1 TRIP13 SLC44A1 PTPRE KRT75 MKI67 PDS5A PLXNB3 | 1.24e-08 | 610 | 132 | 17 | M3854 |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | LPCAT1 DPYSL3 ABCA2 TRO KRT83 SPTBN2 CCT2 CACFD1 HUWE1 TIMMDC1 TRIP13 SLC44A1 PTPRE KRT75 MKI67 PDS5A PLXNB3 | 3.14e-08 | 650 | 132 | 17 | MM1042 |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | LPCAT1 DPYSL3 ABCA2 TRO KRT83 SPTBN2 CCT2 CACFD1 HUWE1 SLC44A1 PTPRE KRT75 MKI67 PDS5A PLXNB3 | 5.21e-07 | 615 | 132 | 15 | M8673 |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | LPCAT1 TRIP13 EDEM3 SHCBP1 MKI67 MACF1 PDS5A AKAP11 EIF3A ALDH5A1 | 5.87e-07 | 250 | 132 | 10 | M11318 |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | LPCAT1 DPYSL3 ABCA2 TRO KRT83 SPTBN2 CCT2 CACFD1 HUWE1 SLC44A1 PTPRE KRT75 MKI67 PDS5A PLXNB3 | 1.23e-06 | 659 | 132 | 15 | MM1040 |
| Coexpression | BENPORATH_SOX2_TARGETS | PRPSAP1 DPYSL3 COPB1 KIF26A APEX1 HUWE1 XAB2 ZCCHC3 VPS52 SLC44A1 VCAN MAST1 ALDH7A1 ARMC6 | 2.10e-05 | 734 | 132 | 14 | M3835 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | ZBTB33 COPB1 DSG2 TSC1 CCT2 XRCC5 TEX10 SRPRB DDX27 SH3BP4 GPD1L EDEM2 MACF1 TMEM131 PSMD14 ALDH5A1 DYNC1H1 SOS2 | 3.95e-05 | 1215 | 132 | 18 | M41122 |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_DN | 6.92e-05 | 199 | 132 | 7 | M7341 | |
| Coexpression | GSE39556_CD8A_DC_VS_NK_CELL_UP | 7.15e-05 | 200 | 132 | 7 | M9406 | |
| Coexpression | GSE42724_B1_BCELL_VS_PLASMABLAST_DN | 7.15e-05 | 200 | 132 | 7 | M9789 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 8.15e-05 | 276 | 132 | 8 | M3063 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.00e-07 | 174 | 132 | 7 | 41eb0a214a8b4015a26311f77061c8147144f0e7 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.62e-06 | 190 | 132 | 7 | 0e9847d7f49b2236b8a191e1a7df37556351ba9e | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.62e-06 | 190 | 132 | 7 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.68e-06 | 191 | 132 | 7 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | ASK440-Epithelial-Type_2|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.06e-06 | 197 | 132 | 7 | 08d5bbeb77a4152af1c783bc958afcae24667767 | |
| ToppCell | 18-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 2.20e-06 | 199 | 132 | 7 | 7ac35e8f45dcdc702422dabd8f3e4d03e2bf61af | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.20e-06 | 199 | 132 | 7 | cdcdef1d95a8e476de016b1e11ee010438834be0 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.93e-06 | 146 | 132 | 6 | 86cddd0e7f954547b7ffdccb0329cd5c4b725ac1 | |
| ToppCell | Int-URO-Myeloid-tDC|Int-URO / Disease, Lineage and Cell Type | 9.93e-06 | 165 | 132 | 6 | 9803c3db6cdcf925bea7d9c382bf4fd05acf3509 | |
| ToppCell | Dividing_Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.03e-05 | 166 | 132 | 6 | c503036f3c19ef186e1e62c9643c49dea3827f51 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.73e-05 | 182 | 132 | 6 | a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50 | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.96e-05 | 186 | 132 | 6 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 187 | 132 | 6 | a2076599b33ae6750961b573bfebcb9036fa4ee8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 187 | 132 | 6 | 38ee33295a21db4aae5ba085df033db9693e41c6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 187 | 132 | 6 | dbcec24d2c852964736c78e9d81650bff5c455ae | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-05 | 188 | 132 | 6 | 7471c194276161422326647f09022e94f3d1640c | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-05 | 188 | 132 | 6 | 053c251d3ddbeb866f34565aefca4535517b4387 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.21e-05 | 190 | 132 | 6 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 2.21e-05 | 190 | 132 | 6 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.27e-05 | 191 | 132 | 6 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.27e-05 | 191 | 132 | 6 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.34e-05 | 192 | 132 | 6 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.41e-05 | 193 | 132 | 6 | 469a7f1c2ff7137cc5a064464456911f67f92e70 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.41e-05 | 193 | 132 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 2.48e-05 | 194 | 132 | 6 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.48e-05 | 194 | 132 | 6 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.48e-05 | 194 | 132 | 6 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.55e-05 | 195 | 132 | 6 | 8ab45ab94c722c4aef0229ee1121cd744bf659dd | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.55e-05 | 195 | 132 | 6 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.63e-05 | 196 | 132 | 6 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | ASK452-Epithelial-Transformed_epithelium|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.70e-05 | 197 | 132 | 6 | e92757e988888347c74286cc42c262b03159b0b9 | |
| ToppCell | ASK428-Epithelial-Type_2|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.78e-05 | 198 | 132 | 6 | ec0d1801363adb70c6a26655b79d12b438c7417d | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.78e-05 | 198 | 132 | 6 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.86e-05 | 199 | 132 | 6 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | normal_Lung-Endothelial_cells-Tip-like_ECs|normal_Lung / Location, Cell class and cell subclass | 2.86e-05 | 199 | 132 | 6 | 1ae0b47fade7b1cd74c0faabcf4f12f56f62264e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.86e-05 | 199 | 132 | 6 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.86e-05 | 199 | 132 | 6 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.94e-05 | 200 | 132 | 6 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.94e-05 | 200 | 132 | 6 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.94e-05 | 200 | 132 | 6 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.94e-05 | 200 | 132 | 6 | ad777683adeb2ce45ade570386235e311fa7ea2d | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.94e-05 | 200 | 132 | 6 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Sepsis-Int-URO-Myeloid-tDC|Int-URO / Disease, condition lineage and cell class | 2.94e-05 | 200 | 132 | 6 | f5d0497a72da21cad24e0ef51c3dc4d024dbf294 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.94e-05 | 200 | 132 | 6 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.94e-05 | 200 | 132 | 6 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.94e-05 | 200 | 132 | 6 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.94e-05 | 200 | 132 | 6 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-lymphoid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.02e-05 | 152 | 132 | 5 | acfafdb64bd5b0eb7371b04cfef51ed2798e9b30 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-common_lymphoid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.02e-05 | 152 | 132 | 5 | 9d6c88ceca0569dbeb12e488acec7fcb7f972f03 | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.31e-05 | 153 | 132 | 5 | 0ef7c45cdd854c79e527006034029767f8e108b2 | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-SC_&_Eosinophil|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.08e-04 | 158 | 132 | 5 | 0d4fe87fc7901dd5f9c004e91708a03cafdb4ad9 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-A_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.29e-04 | 164 | 132 | 5 | beaa13a75c3bb72446c85084d75e9fe3f15fd3d4 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 1.29e-04 | 164 | 132 | 5 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | 343B-Epithelial_cells-Epithelial-A_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.29e-04 | 164 | 132 | 5 | d005cfd821b87548b075120bffe65a0be9860463 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_1|COVID-19_Mild / Disease condition and Cell class | 1.33e-04 | 165 | 132 | 5 | ef709c5d3231c65d351316e1e31b9c9eba721628 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231|Adult / Lineage, Cell type, age group and donor | 1.40e-04 | 167 | 132 | 5 | 5af9127bae05768a5164d5708a4ad37edca99324 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.40e-04 | 167 | 132 | 5 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 168 | 132 | 5 | d69452e2cfeb74023b5cf3d09064d7dcad0008ec | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 169 | 132 | 5 | c7fc3a8c44f07c557b60d469717b66e2f5863d38 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.48e-04 | 169 | 132 | 5 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-H|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.61e-04 | 172 | 132 | 5 | eb199c279fe8a2551121db37e9556893197d33ff | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.61e-04 | 172 | 132 | 5 | dd9ba79e1542fe9fa2c319077d83dd3fc0158f46 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-H-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.61e-04 | 172 | 132 | 5 | 709c6b77a7a52b873eefb6caca28a41291d384af | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.65e-04 | 173 | 132 | 5 | 20889aa85e36ad3bafdb91b91e43964493c949f9 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.65e-04 | 173 | 132 | 5 | 46e601b7938b1dd0aa3df7aa056c4bd07b1620c1 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.84e-04 | 177 | 132 | 5 | ac8f774596068e66c0a9ea8a318be0ce5f5df834 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.84e-04 | 177 | 132 | 5 | d9c4a93b0e04a13bf39992dd1c1ec8df2c5f89fe | |
| ToppCell | COVID-19_Mild-Hematopoietic_SC-HSPC|COVID-19_Mild / Disease group, lineage and cell class | 1.94e-04 | 179 | 132 | 5 | 19fcf48f5e02e4cb2b328efb4502f337e1282f72 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.94e-04 | 179 | 132 | 5 | 4bb2debfc9e9f258cd38e797ef160bd440aad6af | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.94e-04 | 179 | 132 | 5 | 61dbfc1b9b0344c06a68142c181cd62993556a67 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.94e-04 | 179 | 132 | 5 | 2f690f933bf6b99abeb31766e0b22bdbe36c1ba0 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.94e-04 | 179 | 132 | 5 | 3e2c937369b8190fd5d5a31689d029e6e89fb5e2 | |
| ToppCell | COVID-19_Mild-Hematopoietic_SC|COVID-19_Mild / Disease group, lineage and cell class | 1.94e-04 | 179 | 132 | 5 | 50a073166e34bcfa52a62c4dafb3aef724e0fa8e | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.04e-04 | 181 | 132 | 5 | e7f7b519c2a01c15f26df11ec9b434c0d1630c7a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 181 | 132 | 5 | c26d3cbbc592299786d79d1b15fc6bead2aafb9a | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.04e-04 | 181 | 132 | 5 | 54a19cf6a3b752e2391feb8b316bebee0e602d17 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.04e-04 | 181 | 132 | 5 | 5b84625b1d3737708001b64f6da9360330d39a27 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-04 | 181 | 132 | 5 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-1|bone_marrow / Manually curated celltypes from each tissue | 2.04e-04 | 181 | 132 | 5 | ccd0ed30cea3fb41d34f28b3e8d80a94493bef3c | |
| ToppCell | 390C-Epithelial_cells-Epithelial-A_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.07e-04 | 98 | 132 | 4 | a74fb790c135bd0d0033df3aca7b789d8b25e361 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-A_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.07e-04 | 98 | 132 | 4 | cb0941481aef9068d7dbce0d1b6cf125f482a98d | |
| ToppCell | CD8+_Memory_T_cell-RSV-2|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.09e-04 | 182 | 132 | 5 | f5f17a80552f0ad05ed1a2529a04ee55deb1e130 | |
| ToppCell | healthy_donor-Myeloid-Monocytic-SC_&_Eosinophil|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.09e-04 | 182 | 132 | 5 | 6bd6c32c48fecd6d03ac8a09e405b3b99bdc12ae | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.20e-04 | 184 | 132 | 5 | bba0138c8f7e3645a688b9a4d12f6f2134ee2c08 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_conventional_dendritic_(19)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.20e-04 | 184 | 132 | 5 | 315bb14e848d8e8e4533122047df6f9b89b89d99 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.20e-04 | 184 | 132 | 5 | eaef1dcde60ba14e2c7fd699d01c225487256d82 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.20e-04 | 184 | 132 | 5 | fa73738350654066d7f9ebf78359e20ee6cbdd98 | |
| ToppCell | AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.26e-04 | 185 | 132 | 5 | 3b3268e3f99121124e33086cac88479808d31630 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.26e-04 | 185 | 132 | 5 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.26e-04 | 185 | 132 | 5 | 7460387f48f33674330bd53b759681b264228f5a | |
| ToppCell | Mild-NK|World / Disease group and Cell class | 2.26e-04 | 185 | 132 | 5 | 0565b7c464e1a09e596f5a0b363d2dc9b55c3c50 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.32e-04 | 186 | 132 | 5 | 9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.37e-04 | 187 | 132 | 5 | 7c44cec1c26ca5907a495f2d7e633410e2e9728f | |
| ToppCell | control-Lymphocytic-Plasmablast|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.37e-04 | 187 | 132 | 5 | 94a44b31ce9fe6fb4758769018fb746e93c8f043 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.37e-04 | 187 | 132 | 5 | 97b2463fb37e7196dd2f92553acf8e7bc3ec40dd | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.43e-04 | 188 | 132 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.43e-04 | 188 | 132 | 5 | 0026c9479b30fb39daa91cfa220a88f9c9e65fe7 | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.43e-04 | 188 | 132 | 5 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.43e-04 | 188 | 132 | 5 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.43e-04 | 188 | 132 | 5 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| Drug | 3-Acetamidocoumarin [779-30-6]; Up 200; 19.6uM; HL60; HT_HG-U133A | DPYSL3 ABCA2 TNPO2 HIP1R XAB2 SERPINE1 GNA11 ALDH5A1 ARHGAP33 ARMC6 | 2.23e-07 | 196 | 132 | 10 | 2941_UP |
| Disease | Uveal melanoma | 4.39e-06 | 8 | 128 | 3 | C0220633 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 1.11e-05 | 67 | 128 | 5 | EFO_0008595, EFO_0020946 | |
| Disease | Phakomatosis cesioflammea | 1.87e-05 | 2 | 128 | 2 | C3838883 | |
| Disease | Congenital hemangioma | 1.87e-05 | 2 | 128 | 2 | C0235753 | |
| Disease | Port-wine stain with oculocutaneous melanosis | 1.87e-05 | 2 | 128 | 2 | C1274879 | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 1.11e-04 | 4 | 128 | 2 | DOID:0050882 (implicated_via_orthology) | |
| Disease | diacylglycerol 33:1 measurement | 1.11e-04 | 4 | 128 | 2 | EFO_0020056 | |
| Disease | Malignant melanoma of iris | 1.85e-04 | 5 | 128 | 2 | C0346373 | |
| Disease | Malignant melanoma of choroid | 1.85e-04 | 5 | 128 | 2 | C0346388 | |
| Disease | linoleoyl-linoleoyl-glycerol (18:2/18:2) [1] measurement | 1.85e-04 | 5 | 128 | 2 | EFO_0800510 | |
| Disease | diacylglycerol 44:6 measurement | 1.85e-04 | 5 | 128 | 2 | EFO_0020070 | |
| Disease | diacylglycerol 36:1 measurement | 2.77e-04 | 6 | 128 | 2 | EFO_0010354 | |
| Disease | diacylglycerol 34:0 measurement | 3.87e-04 | 7 | 128 | 2 | EFO_0020058 | |
| Disease | triglyceride measurement, metabolic syndrome | 5.14e-04 | 8 | 128 | 2 | EFO_0000195, EFO_0004530 | |
| Disease | head and neck squamous cell carcinoma (is_marker_for) | 5.14e-04 | 8 | 128 | 2 | DOID:5520 (is_marker_for) | |
| Disease | vitamin K measurement | 6.59e-04 | 9 | 128 | 2 | EFO_0004618 | |
| Disease | apolipoprotein A-V measurement | 6.59e-04 | 9 | 128 | 2 | EFO_0801387 | |
| Disease | triglyceride measurement, blood pressure | 6.59e-04 | 9 | 128 | 2 | EFO_0004325, EFO_0004530 | |
| Disease | diacylglycerol 36:4 measurement | 6.59e-04 | 9 | 128 | 2 | EFO_0020063 | |
| Disease | vitamin D measurement | 6.80e-04 | 336 | 128 | 7 | EFO_0004631 | |
| Disease | docosahexaenoic acid measurement, fatty acid measurement | 7.01e-04 | 40 | 128 | 3 | EFO_0005110, EFO_0007761 | |
| Disease | Cutaneous Melanoma | 7.53e-04 | 41 | 128 | 3 | C0151779 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 8.09e-04 | 42 | 128 | 3 | EFO_0008317, EFO_0008596, EFO_0020945 | |
| Disease | diacylglycerol 32.2 measurement | 8.21e-04 | 10 | 128 | 2 | EFO_0020055 | |
| Disease | diacylglycerol 34:3 measurement | 1.00e-03 | 11 | 128 | 2 | EFO_0020059 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 1.07e-03 | 103 | 128 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | level of Phosphatidylinositol (16:0_18:1) in blood serum | 1.20e-03 | 12 | 128 | 2 | OBA_2045152 | |
| Disease | sterol measurement | 1.41e-03 | 13 | 128 | 2 | EFO_0010231 | |
| Disease | Prostatic Neoplasms | 1.50e-03 | 616 | 128 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.50e-03 | 616 | 128 | 9 | C0376358 | |
| Disease | platelet component distribution width | 1.71e-03 | 755 | 128 | 10 | EFO_0007984 | |
| Disease | Sinus Node Dysfunction (disorder) | 1.89e-03 | 15 | 128 | 2 | C0428908 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 1.94e-03 | 121 | 128 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | level of triacylglycerol (56:6) in blood serum | 2.15e-03 | 16 | 128 | 2 | OBA_2020007 | |
| Disease | cholesteryl ester 16:1 measurement | 2.15e-03 | 16 | 128 | 2 | EFO_0010342 | |
| Disease | diacylglycerol 36:2 measurement | 2.15e-03 | 16 | 128 | 2 | EFO_0010355 | |
| Disease | diacylglycerol 44:7 measurement | 2.15e-03 | 16 | 128 | 2 | EFO_0020069 | |
| Disease | hypertension | 2.27e-03 | 307 | 128 | 6 | EFO_0000537 | |
| Disease | cholesterol to total lipids in IDL percentage | 2.28e-03 | 60 | 128 | 3 | EFO_0022233 | |
| Disease | obesity (implicated_via_orthology) | 2.51e-03 | 215 | 128 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | diacylglycerol 36:3 measurement | 2.73e-03 | 18 | 128 | 2 | EFO_0020062 | |
| Disease | platelet crit | DENND2A DNAH3 KIF26A TCIM LRRK2 OSER1 ST7L SH3BP4 PNPLA3 EIF3A RHOF | 2.94e-03 | 952 | 128 | 11 | EFO_0007985 |
| Disease | Hypertriglyceridemia | 3.04e-03 | 19 | 128 | 2 | EFO_0004211 | |
| Disease | bilirubin measurement | 3.23e-03 | 442 | 128 | 7 | EFO_0004570 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 3.29e-03 | 229 | 128 | 5 | EFO_0004639, EFO_0008317 | |
| Disease | citrulline measurement | 3.37e-03 | 20 | 128 | 2 | EFO_0009777 | |
| Disease | free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 3.71e-03 | 21 | 128 | 2 | EFO_0022277 | |
| Disease | cardiovascular disease | 3.88e-03 | 457 | 128 | 7 | EFO_0000319 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VEAIREALVDKAEAF | 81 | P20813 | |
| FRSQAAVIDEIVDTT | 756 | Q8NEC5 | |
| IAIDQESQKIAFARA | 1551 | P13611 | |
| TALKQRSFVDAEVDV | 206 | Q6P1J9 | |
| RSFVDAEVDVTRDIV | 211 | Q6P1J9 | |
| NAIIAFEDADLSLVV | 301 | P49419 | |
| REALNTKEAVVFEAV | 291 | Q96KE9 | |
| IAQETFDAAVRENIE | 31 | Q6NXE6 | |
| LEAEAVFRAITIASQ | 231 | Q14195 | |
| QFIEFANTVAEKVDR | 81 | Q9UGQ2 | |
| DAEERKVTAIQTEVF | 3156 | Q96DT5 | |
| EEIQRVAEVANAVAF | 601 | Q9NRK6 | |
| NTVARFAADLAEELV | 641 | Q9UKA4 | |
| IAAFTRAIDQETEEV | 296 | Q6Q788 | |
| RVIVAEFDSFVLVTA | 156 | P27695 | |
| FIVQTAEIAEIARLS | 1316 | Q9Y4F5 | |
| RNEVVVQAAAVRVSD | 436 | Q9NVE4 | |
| DEQIDILVATDVAAR | 511 | Q96GQ7 | |
| SEVDEQVRLLAEKVF | 11 | Q01432 | |
| EVQKDQFVFREIIAD | 121 | Q9H2T7 | |
| DDKVAEAAIQIFRNT | 691 | Q29RF7 | |
| KDATNVAAAFEEAVR | 156 | P51151 | |
| VAAAFEEAVRRVLAT | 161 | P51151 | |
| KDDTNVTVAFEEAVR | 156 | Q9NP90 | |
| VTVAFEEAVRQVLAV | 161 | Q9NP90 | |
| NASEKTVVEALFQRD | 246 | P57740 | |
| QLVREVDVEKVSAFE | 111 | P50148 | |
| ATDTENIRFVFAAVK | 331 | P50148 | |
| EFALTAVAEEVNAIL | 996 | Q92932 | |
| SFEEVAREGADVIVN | 166 | P14920 | |
| VNVEVTRIKVFDADE | 286 | Q14126 | |
| EVVDARLVSVFDARE | 1431 | Q9P2P5 | |
| HAEQKVDVFEFVSRI | 356 | P23469 | |
| VAELTVTDLFRAIDQ | 451 | Q8NF37 | |
| VERADALQLSVEEFV | 46 | Q6NYC1 | |
| ADVAIELKAVFTDRQ | 81 | Q3ZCW2 | |
| QVVELSFIRAEIFAE | 66 | Q86T24 | |
| LSEAVQDADLLVFVI | 81 | Q8N335 | |
| TEFAVLEEQRVELSV | 226 | Q17R60 | |
| ENTQAEARKDFVVAV | 3206 | Q8NDA2 | |
| VDRIFSFEINVSVAI | 281 | P06681 | |
| LRDVNLDNDVVVSVF | 131 | Q9BZQ6 | |
| LDNDVVVSVFETNIR | 136 | Q9BZQ6 | |
| RVVEVLQDSVDFDID | 96 | Q9BV94 | |
| AEAEQKAFEVIATER | 461 | O43439 | |
| FDVRVSDNVDAILAV | 1771 | Q9ULL4 | |
| EATREFNVVIVAVDS | 496 | O60245 | |
| SANKVFEELTDVERQ | 246 | P51160 | |
| NVLVSDFRSKDEVVD | 126 | Q9NST1 | |
| AAADVLEFVREAIQR | 416 | P53618 | |
| VLFERVSEEQLTEFV | 186 | Q5S007 | |
| SVSFEQAVRILQDDV | 126 | Q13601 | |
| AEAAVAAVAVADTVR | 246 | Q9ULI4 | |
| ATIVDVDDQRVKVHF | 316 | Q8NA19 | |
| VEKAVRAARQAADFT | 181 | Q15274 | |
| AEQQITEVFVLAERI | 3101 | P46013 | |
| RFVAAEQSVALGEEV | 576 | Q96MM6 | |
| DEQDQITFVTRAVRV | 421 | Q7Z6Z7 | |
| TFEEDKVNSALVVDR | 501 | Q3BBV0 | |
| IQQAFVERDILTFAE | 416 | Q9Y2H9 | |
| IVDIFSDQRVTLVEA | 2736 | Q9UPN3 | |
| ETLVFSENAVVALRD | 196 | Q9UNX9 | |
| AAFQAETQELLDVIV | 291 | O95248 | |
| ITEKIDVAFVDRADI | 301 | Q15645 | |
| QVEIIRDFDVAVVTF | 181 | Q460N5 | |
| RDFDVAVVTFQKHID | 186 | Q460N5 | |
| AAAFREVRVQSVVVE | 486 | O14559 | |
| VREALVQQAEVFSDR | 136 | Q7Z449 | |
| EEAELEANSVFRQKV | 396 | Q5EBM0 | |
| EAEREQFDKTQAISI | 21 | O75146 | |
| TNRVIFLEDDDIAAV | 271 | O94808 | |
| DEFNRIEVEVLSVVA | 1481 | Q8TD57 | |
| NEVVSEAFVRFFVEI | 896 | Q9ULE3 | |
| FVDAFQLERAIVDAA | 461 | Q14152 | |
| ATDTENIRFVFAAVK | 331 | P29992 | |
| ARDVFAQVREATADI | 666 | Q6PD62 | |
| SEVDRVILKANETFA | 466 | Q9BZC7 | |
| IFNRVVLENEAVRAA | 476 | Q9UBF2 | |
| VVAVAARDLSRAKEF | 31 | Q9UQ10 | |
| IVNFSAEEISDAIRE | 3351 | Q14204 | |
| RAVVIFANDEDIKQI | 281 | Q14831 | |
| DVESFVAAAEILKER | 261 | Q14558 | |
| KDAFVILVENALRVA | 516 | Q8WWI5 | |
| FDEFNRISVEVLSVV | 1921 | Q9NYC9 | |
| ARFLENVAAAETEKQ | 441 | Q9Y613 | |
| VFLAIAVDNLADAES | 746 | Q01668 | |
| EEVALRATAENEFVA | 201 | P78385 | |
| QSFEALSERAVAVVV | 131 | O00487 | |
| AAAEEINTKEVAQRI | 316 | O60422 | |
| QVDFSEVERARFIIN | 146 | P05121 | |
| EEVVFVRLNTEVASV | 261 | O14654 | |
| VEDVFREAAKVALSA | 181 | Q9HBH0 | |
| AAQRLATVVNDERFV | 196 | Q9HCS7 | |
| FVVDSAAFQREVKDV | 141 | Q9Y5M8 | |
| EEVAIKRENFVAEIQ | 486 | P49590 | |
| RADDLIETAKVFVNN | 121 | Q6ZUK4 | |
| CIVEAENFEERVAVL | 836 | Q07890 | |
| VIKFDTEEEAIAIAN | 446 | P51649 | |
| DFTLRVQVKDDQEAI | 586 | Q9P0V3 | |
| VQFSVEDVVEVNILR | 1276 | Q8NDG6 | |
| AVVEEETSFLRARVQ | 31 | P56278 | |
| EEIFDSRIAAQAVTK | 31 | Q8NHV1 | |
| EKVDAVRLINIVFDE | 351 | Q96BP3 | |
| AVLFDITEDRAAAEQ | 136 | Q68DV7 | |
| SAAEAAEVILRVDNI | 506 | P78371 | |
| VLVEITDVDFAALKA | 126 | Q8NEM2 | |
| TDVDFAALKAVVRLA | 131 | Q8NEM2 | |
| DFASEAEVAVQKEIR | 2461 | Q9P2P6 | |
| FVNLVDLSEVAEVSR | 211 | Q6P1J6 | |
| QARVFVDDVTIEDLS | 256 | Q9NX31 | |
| AVRALEQFATVVEAK | 536 | P49748 | |
| VDTEQDRVFFIKAIA | 56 | Q96AJ1 | |
| ESADVVAFILRQVIE | 866 | O00562 | |
| VEVENFVLRVAAEFS | 541 | Q8N1B4 | |
| ANKDATAERIDEFIV | 166 | O75312 | |
| VRDDVTAVFKENLNS | 21 | Q92574 | |
| FILFRNETVDVEDIV | 256 | Q9NUD5 | |
| EVRKEIEDAAQFATA | 341 | P08559 | |
| VQAVDAVAAELAAER | 481 | O15020 | |
| EAAAVRDISEVSVFD | 46 | Q5JNZ5 | |
| EVQAAAVAVAEAEAR | 646 | Q12816 | |
| FAAASREVLAVEAEL | 111 | Q96EN9 | |
| RVFAAEAVTADSEVL | 21 | Q9NPL8 | |
| SAAALDVLANVFREE | 376 | O14787 | |
| TLVVAAARAEKEAFV | 51 | Q92545 | |
| AARAEKEAFVQSESI | 56 | Q92545 | |
| EDEAQAFRALVQEKI | 131 | P42768 | |
| SEVTAVFTDKDANVR | 101 | Q9NXF1 | |
| VFTDKDANVRLAAVQ | 106 | Q9NXF1 | |
| ALQVRVVEAEQLFAE | 851 | Q9H254 | |
| EATTIVDAERLFKQA | 246 | Q8TDW4 | |
| FVEQTDIVALAARAI | 1126 | Q68DE3 | |
| EAVTFKDVAVVFSRE | 21 | Q86WZ6 | |
| AFNSAERAVTEVREV | 1461 | Q9Y4F4 | |
| IIFAIDQDVEEKTRA | 66 | Q9NR00 | |
| AAVADAILRAQEEIF | 346 | O14939 | |
| VLKVFAARDDEAAAV | 361 | P13010 | |
| REDFEKTIAEQAVAA | 111 | Q02108 | |
| DEINKRTAAENEFVA | 241 | O95678 | |
| EVEINRRTTAENEFV | 231 | Q7RTS7 | |
| LVTAVEKFEAEAAAL | 621 | Q9UQQ1 |